Compugen Ltd
CGEN1.670USD
+0.080+5.03%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
156.20MValor de mercado
PerdaP/L TTM
Mais detalhes de Compugen Ltd Empresa
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Informações de Compugen Ltd
Código da empresaCGEN
Nome da EmpresaCompugen Ltd
Data de listagemAug 01, 2000
CEOOphir (Eran)
Número de funcionários74
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 01
EndereçoAzrieli Center
CidadeHOLON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal5885849
Telefone97237658585
Sitehttps://cgen.com/
Código da empresaCGEN
Data de listagemAug 01, 2000
CEOOphir (Eran)
Executivos da empresa Compugen Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Anat Cohen-Dayag, Ph.D.
Dr. Anat Cohen-Dayag, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
56.12K
--
Dr. Kinneret Livnat Savitsky, Ph.D.
Dr. Kinneret Livnat Savitsky, Ph.D.
Independent Director
Independent Director
--
--
Dr. Zurit Levine, Ph.D.
Dr. Zurit Levine, Ph.D.
Senior Vice President, Technology Innovation
Senior Vice President, Technology Innovation
--
--
Mr. Paul Jai Sekhri
Mr. Paul Jai Sekhri
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gilead Halevy
Mr. Gilead Halevy
Independent Director
Independent Director
--
--
Mr. Sanford (Sandy) Zweifach, CPA
Mr. Sanford (Sandy) Zweifach, CPA
Independent Director
Independent Director
--
--
Mr. Eran Perry
Mr. Eran Perry
Independent Director
Independent Director
--
--
Dr. Oliver Froescheis, Ph.D.
Dr. Oliver Froescheis, Ph.D.
Senior Vice President, Corporate and Business Development
Senior Vice President, Corporate and Business Development
--
--
Dr. Yaron Turpaz, Ph.D.
Dr. Yaron Turpaz, Ph.D.
Senior Vice President, Senior Advisor, Computational Discovery
Senior Vice President, Senior Advisor, Computational Discovery
--
--
Ms. Yvonne Naughton, Ph.D.
Ms. Yvonne Naughton, Ph.D.
Head of Investor Relations and Corporate Communications
Head of Investor Relations and Corporate Communications
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Anat Cohen-Dayag, Ph.D.
Dr. Anat Cohen-Dayag, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
56.12K
--
Dr. Kinneret Livnat Savitsky, Ph.D.
Dr. Kinneret Livnat Savitsky, Ph.D.
Independent Director
Independent Director
--
--
Dr. Zurit Levine, Ph.D.
Dr. Zurit Levine, Ph.D.
Senior Vice President, Technology Innovation
Senior Vice President, Technology Innovation
--
--
Mr. Paul Jai Sekhri
Mr. Paul Jai Sekhri
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gilead Halevy
Mr. Gilead Halevy
Independent Director
Independent Director
--
--
Mr. Sanford (Sandy) Zweifach, CPA
Mr. Sanford (Sandy) Zweifach, CPA
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
22.86M
82.06%
Europe
5.00M
17.94%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: sáb, 15 de nov
Atualizado em: sáb, 15 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
SilverArc Capital Management, LLC
3.54%
Bristol Myers Squibb
1.97%
Renaissance Technologies LLC
1.50%
Nomura Investment Management Business Trust
1.09%
Morgan Stanley Smith Barney LLC
0.93%
Outro
90.97%
Investidores
Investidores
Proporção
SilverArc Capital Management, LLC
3.54%
Bristol Myers Squibb
1.97%
Renaissance Technologies LLC
1.50%
Nomura Investment Management Business Trust
1.09%
Morgan Stanley Smith Barney LLC
0.93%
Outro
90.97%
Tipos de investidores
Investidores
Proporção
Hedge Fund
6.18%
Investment Advisor
5.29%
Corporation
1.97%
Investment Advisor/Hedge Fund
1.38%
Research Firm
0.58%
Individual Investor
0.06%
Family Office
0.04%
Bank and Trust
0.02%
Outro
84.48%
Participação acionária institucional
Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
119
12.73M
17.35%
--
2025Q3
125
12.73M
18.34%
-2.70M
2025Q2
126
16.23M
19.87%
+39.65K
2025Q1
133
16.24M
16.64%
+1.34M
2024Q4
138
13.37M
17.09%
+210.15K
2024Q3
152
13.17M
21.08%
-305.68K
2024Q2
162
13.42M
29.55%
-531.69K
2024Q1
196
13.93M
29.95%
-12.89M
2023Q4
205
11.91M
32.36%
-1.05M
2023Q3
223
12.99M
32.04%
+1.17M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
SilverArc Capital Management, LLC
3.31M
3.54%
+277.29K
+9.14%
Sep 30, 2025
Bristol Myers Squibb
1.84M
1.97%
-2.92M
-61.32%
Dec 31, 2024
Renaissance Technologies LLC
1.41M
1.5%
+78.23K
+5.90%
Sep 30, 2025
Nomura Investment Management Business Trust
1.02M
1.09%
--
--
Sep 30, 2025
Morgan Stanley Smith Barney LLC
870.81K
0.93%
+27.78K
+3.30%
Sep 30, 2025
Taylor Frigon Capital Management LLC
964.71K
1.03%
-29.94K
-3.01%
Sep 30, 2025
Northern Trust Global Investments Limited
658.91K
0.7%
-230.81K
-25.94%
Sep 30, 2025
Two Sigma Investments, LP
455.66K
0.49%
+113.23K
+33.07%
Sep 30, 2025
State Street Investment Management (US)
379.10K
0.41%
+27.92K
+7.95%
Sep 30, 2025
UBS Financial Services, Inc.
296.60K
0.32%
+6.17K
+2.13%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
SPDR S&P International Small Cap ETF
0.01%
Invesco NASDAQ Future Gen 200 ETF
0%
ARK Israel Innovative Technology ETF
0%
SPDR Portfolio Developed World ex-US ETF
0%
SPDR S&P International Small Cap ETF
Proporção0.01%
Invesco NASDAQ Future Gen 200 ETF
Proporção0%
ARK Israel Innovative Technology ETF
Proporção0%
SPDR Portfolio Developed World ex-US ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
